VivoSim Labs (VIVS) Change in Receivables (2011 - 2026)
VivoSim Labs (VIVS) posted Change in Receivables of -$3000.0 for Q2 2026, down 200.0% on a QoQ basis from -$1000.0 in Q1 2026, and down 250.0% year-over-year from $2000.0 in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) Change in Receivables (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Change in Receivables for 13 years, with the latest figure at -$3000.0 in Q2 2026.
- On a quarterly basis, Change in Receivables fell 250.0% year-over-year to -$3000.0 in Q2 2026; TTM through Jun 2026 was -$3000.0, a 81.25% increase from a year earlier, with the FY2026 full-year figure at $2000.0, up 166.67% from the prior year.
- Change in Receivables was -$3000.0 for Q2 2026 at VivoSim Labs, down from -$1000.0 in the prior quarter.
- The five-year high for Change in Receivables was $76000.0 in Q4 2022, with the low at -$94000.0 in Q3 2023.
- Average Change in Receivables over 5 years is $2230.8, with a median of -$1000.0 recorded in 2026.
- The sharpest annual moves came in 2024 and 2026: Change in Receivables soared 600.0% in 2024, then sank 250.0% in 2026.
- Over 5 years, Change in Receivables stood at $76000.0 in 2022, then plunged by 128.95% to -$22000.0 in 2023, then soared by 86.36% to -$3000.0 in 2024, then surged by 133.33% to $1000.0 in 2025, then plunged by 400.0% to -$3000.0 in 2026.
- The last three Change in Receivables figures came in at -$3000.0 (Q2 2026), -$1000.0 (Q1 2026), and $1000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 47.18 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -43.54 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 21.82 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -3.71 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 414,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 416,693.85 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | -94,000.00 |
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | 76,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Dec 31, 2020 | -19,000.00 |
| Sep 30, 2020 | -65,000.00 |
| Jun 30, 2020 | -27,000.00 |
| Mar 31, 2020 | -43,000.00 |
| Dec 31, 2019 | -465,000.00 |
| Sep 30, 2019 | 81,000.00 |
| Jun 30, 2019 | 35,000.00 |